Clinical Trial Finds Ketamine Not Effective For Depression

By Dennis Thompson HealthDay ReporterTUESDAY, Oct. 28, 2025 (HealthDay News) — Ketamine might not be effective in treating ...
Reuters

CORRECTED-BRIEF-UCB's Midazolam Nasal Spray Granted Orphan Drug Designation

* MIDAZOLAM NASAL SPRAY HAS ALSO BEEN GRANTED FAST TRACK DESIGNATION BY THE US FDA DUE TO THE HIGH UNMET NEED FOR PATIENTS AND CAREGIVERS * MIDAZOLAM NASAL SPRAY HAS BEEN GRANTED ORPHAN DRUG ...
MedPage Today on MSN

Trial Questions Ketamine Use for Patients Hospitalized With Depression

A 2022 study showed that 28.3% of patients receiving ketamine had a billing diagnosis of depression. McLoughlin's group ...
Medscape

Medical Students News

Alert FDA OKs Midazolam Nasal Spray (Nayzilam) for Seizure Clusters Nayzilam is the first FDA-approved nasal option for treating seizure clusters that are distinct from a patient's usual seizure ...
KXAN

NAYZILAM® (midazolam) Results Published in 'Epilepsy & Behavior' Examining the Impact of Dose on Return to Full Baseline Function (RTFBF) for People with Seizure Clusters

The Phase 3 open-label extension (OLE) study evaluated the safety of repeated, intermittent use of NAYZILAM in individuals living with epilepsy experiencing acute repetitive seizures, also known as ...